Page 1357 - Clinical Small Animal Internal Medicine
P. 1357

143  Exocrine Pancreatic Cancer  1295

                 In a retrospective study evaluating 34 cats with EPC,   Comparatively, about 45 220 people develop cancer of
  VetBooks.ir  metastatic disease was confirmed in 11 cats and overall   the exocrine pancreas each year in the US, and almost all
                                                                  are expected to die from the disease. The median sur-
               median survival was 97 days. The median survival times
               for patients who received chemotherapy or had their
                                                                  disease and less for those with metastatic disease at pres-
               masses surgically removed was 165 days. Patients with   vival is 8–12 months for patients with locally advanced
               abdominal effusion present at diagnosis had a median   entation. Five‐year survival rates are consistently <18%.
               survival of 30 days. Interestingly, however, three patients   The majority of these tumors (85%) are adenocarcino-
               survived over one year.                            mas arising from the ductal epithelium. Surgical resec-
                 A cat with metastatic EPC to the spleen treated with   tion  offers  the  only  chance of  cure.  However,  only
               partial pancreatectomy and splenectomy was reported   15–20% of patients have resectable disease at diagnosis,
               to be alive and disease free >2 years later. Therefore, the   approximately 40% have metastatic disease, and another
               prognosis for EPC in select dogs and cats may not be as   30–40% have locally advanced unresectable tumors.
               dismal as previously reported.


                 Further Reading


               Bennett PF, Hahn KA, Toal RL, Legendre AM.         Miller WH, Griffin CE, Campbell KL. Paraneoplastic
                 Ultrasonographic and cytopathological diagnosis of   alopecia. Muller and Kirk’s Small Animal Dermatology,
                 exocrine pancreatic carcinoma in the dog and cat. J Am   7th edn. Philadelphia, PA: Saunders 2013, pp. 558–9.
                 Anim Hosp Assoc 2001; 37(5): 466–73.             Rosatelli P, Menicagli F, Citro G, Baldi A, Spugnini EP.
               Dennis MM, O’Brien TD, Wayne T, Kuipel M, Williams M,   Long‐term survival in a cat with pancreatic carcinoma
                 Powers BE. Hyalinizing pancreatic adenocarcinoma in   and splenic involvement after surgical excision. Case Rep
                 six dogs. Vet Pathol 2008; 45: 475–83.             Vet Med 2011; 2011: article ID 653859.
               Hecht S, Penninick DG, Keating JH. Imaging findings in   Seaman RL. Exocrine pancreatic neoplasia in the cat: a
                 pancreatic neoplasia and nodular hyperplasia in 19 cats.   case series. J Am Anim Hosp Assoc 2004; 40(3): 238–45.
                 Vet Radiol Ultrasound 2007; 48(1): 45–50.        Shearin AL, Ostrander EA. Leading the way: canine
               Linderman MJ, Brodsky EM., Lorimier LP, Clifford CA,   models of genomics and disease. Dis Models
                 Post GA. Feline exocrine pancreatic carcinoma: a   Mechanisms 2010; 3(1‐2): 27–3.
                 retrospective study of 34 cases. Vet Compar Oncol 2013;
                 11(3): 208–18
   1352   1353   1354   1355   1356   1357   1358   1359   1360   1361   1362